MGMT and glioblastoma: Younger age, a better clinical status at diagnosis, tumor location outside of eloquent regions, gross total resection (GTR) of the tumor, and promotor methylation of the O-6-methylguanine-DNA methyltransferase (MGMT) count to the most relevant prognostic factors in GBM patients [3–5].